A-TCP Leader to Co-chair Neuronext Oversight Board at NIH March 1, 2013

Share:

Brad Margus has been tapped to co-chair the oversight board for the Network for Excellence in Neuroscience Clinical Trials, or NeuroNEXT, a new, innovative program at the National Institutes of Health.

NeuroNEXT, will provide a robust, standardized, and expert network of 25 clinical centers across the USA to more quickly test treatments for adults and children with neurological disorders. It promises to alleviate some of the current bottlenecks in the development of new drugs for neurological disorders and could be useful to test promising therapies for A-T.

Oops! We could not locate your form.

Related News

Jan 31, 2025 Feb 16 @ 11:17 pm

Gene Editing for A-T Grant Awarded

We are pleased to announce that funds have been awarded to a researcher with Johns Hopkins University.

more
Dec 31, 2024 Feb 16 @ 11:17 pm

2025 Could Be a Landmark Year for A-T Research

We’re feeling so optimistic about the new year, given the accelerated progress we’re seeing in our search for

more
Dec 4, 2024 Feb 16 @ 11:17 pm

Encouraging Initial Results from an A-T Drug Repurposing Screen

We’re thrilled to share encouraging initial results from a study funded by the A-T Children’s Project and conducted

more
Dec 2, 2024 Feb 16 @ 11:17 pm

Jehlik Family Matched Giving Tuesday Donations for A-T

The Jeff Jehlik Memorial Fund Will Match Your "Giving Tuesday" Donation for A-T up to $100,000!

more